Institution
Parkland Memorial Hospital
Healthcare•Dallas, Texas, United States•
About: Parkland Memorial Hospital is a healthcare organization based out in Dallas, Texas, United States. It is known for research contribution in the topics: Health care & Myocardial infarction. The organization has 405 authors who have published 315 publications receiving 7706 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Current data and theories regarding the pathophysiology of allergic fungal rhinosinusitis, as well as the role of various surgical and nonsurgical forms of therapy are reviewed.
Abstract: The combination of nasal polyposis, crust formation, and sinus cultures yielding Aspergillus was first noted in 1976 by Safirstein,1 who observed the clinical similarity that this constellation of findings shared with allergic bronchopulmonary Aspergillosis (ABPA). Eventually this disease came to be known as allergic fungal rhinosinusitis (AFS). As clinical evidence of AFS accumulated, controversy regarding its etiology, pathogenesis, natural history, and appropriate treatment naturally emerged. Despite past and current efforts, many of these controversies remain incompletely resolved, but continuing clinical study has illuminated some aspects of the disease and has led to an improved understanding of AFS and its treatment. Fungi associated with the development of AFS are ubiquitous and predominantly of the dematiaceous family. The eosinophilic host response to the presence of these fungi within the nose and paranasal sinuses gives rise to those clinical manifestations of the disease (nasal polyps, expansile mucocele formation, allergic fungal mucin, etc.). Exposure alone to these fungi, however, appears to be insufficient to initiate the disease. At the present time it is likely that initiation of the inflammatory cascade leading to AFS is a multifactorial event, requiring the simultaneous occurrence of such things as IgE-mediated sensitivity (atopy), specific T-cell HLA receptor expression, exposure to specific fungi, and aberration of local mucosal defense mechanisms. A variety of treatment plans for AFS have emerged, but the potential for recidivism remains well recognized, ranging from 10% to nearly 100%, suggesting the need for continued study of this disease and fueling present controversy. This article is intended to review current data and theories regarding the pathophysiology of AFS, as well as the role of various surgical and nonsurgical forms of therapy.
244 citations
••
TL;DR: The problem of poor retention of CPR skills may lie not with the learner or the curriculum, but with the instructor, so the solution is to improve instructor training to make certain that students receive adequate practice time and accurate skill evaluation, but also to modify the criteria for correct performance when testing for retention.
225 citations
••
TL;DR: Standardized treatment applied uniformly to all cases of eclampsia at Parkland Memorial Hospital has consisted of magnesium sulfate intravenously and intramuscularly to control convulsions, and steps to effect vaginal delivery as soon as the woman has regained consciousness.
197 citations
••
TL;DR: The incidence of long-term morbidity and mortality is greatly increased after AMI in patients without residual anterograde perfusion of the infarct-related coronary artery, and in these patients, the restoration of partial or complete anterogsrade flow--pharmacologically or mechanically--may be beneficial even if it is accomplished hours to days after the acute event.
Abstract: The restoration of anterograde coronary flow during the hours to days after acute myocardial infarction (AMI) may be beneficial independent of an effect on left ventricular function. This study was done to assess the influence of residual anterograde coronary perfusion on long-term morbidity and mortality in patients after AMI. Over a 10-year period, 179 subjects (132 men, 47 women, aged 25 to 66 years) with infarction and angiographic evidence of disease of only 1 coronary artery were followed for 47 ± 29 (mean ± standard deviation) months. All were receiving medical therapy. Sixty-four patients had partial or complete anterograde perfusion of the infarct artery (group I), whereas the other 115 had no or minimal anterograde perfusion (group II). The 2 groups were similar in age, sex, risk factors for atherosclerotic cardiovascular disease, duration of follow-up, maintenance medications and left ventricular function. In group I, unstable angina and congestive heart failure each occurred in ≤10%, and none died. In marked contrast, the 115 patients in group II frequently had unstable angina (25%) and congestive heart failure (17%) (p ≤ 0.05 for both vs group I), and 21 (18%) died suddenly (p
190 citations
••
TL;DR: The results suggest that dobutamine has a potential inotropic value but raise concern about its influence on regional myocardial perfusion in patients with serious coronary artery disease.
Abstract: The influence of dobutamine on hemodynamics and coronary blood flow was studied in patients after routine cardiac catheterization. The data demonstrated that dobutamine is a powerful inotropic agent at a dose that has a relatively small influence on heart rate. In patients without coronary artery disease dobutamine greatly increased coronary arterial perfusion. In patients with severe coronary artery diseases dobutamine resulted in a much smaller increase in coronary perfusion, and the pattern of perfusion became more inhomogeneous. The results suggest that dobutamine has a potential inotropic value but raise concern about its influence on regional myocardial perfusion in patients with serious coronary artery disease.
177 citations
Authors
Showing all 416 results
Name | H-index | Papers | Citations |
---|---|---|---|
Peter Stone | 130 | 1229 | 79713 |
Jeffrey J. Popma | 121 | 702 | 72455 |
James L. Manley | 109 | 308 | 38574 |
James E. Muller | 95 | 340 | 38497 |
Herman K. Gold | 77 | 208 | 24363 |
Jeffrey M. Perlman | 77 | 318 | 28587 |
Steven E. Wolf | 74 | 419 | 21329 |
Philip Raskin | 67 | 199 | 31106 |
Ronald M Peshock | 66 | 225 | 14570 |
James T. Willerson | 59 | 273 | 15362 |
Mark H. Drazner | 58 | 241 | 31657 |
Robert W. Parkey | 52 | 207 | 8955 |
Mark Feldman | 52 | 150 | 9143 |
Richard A. Lange | 47 | 148 | 10928 |
H. William Strauss | 45 | 156 | 6932 |